Need A G, Horowitz M, Philcox J C, Nordin B E
Department of Endocrinology, Royal Adelaide Hospital, S.A., Australia.
Miner Electrolyte Metab. 1987;13(2):112-6.
Although calcium supplements are widely used to reduce bone resorption in osteoporosis, their beneficial effect is not conclusively established. We have studied the acute (after 12 h) effects of an oral calcium load (1 g) in a group of 35 osteoporotic postmenopausal women, comprising 19 subjects with normal absorption and 16 subjects with malabsorption of calcium. In the subjects with normal calcium absorption the fasting urinary total hydroxyproline/creatinine ratio fell from 0.021 to 0.017 (p less than 0.001), but in those with malabsorption of calcium it did not change significantly. This difference between the two groups was significant (p less than 0.01). These results indicate that an oral calcium load rapidly suppresses bone resorption in osteoporotic subjects with normal absorption of calcium, but not in those with malabsorption of calcium.
尽管钙补充剂被广泛用于减少骨质疏松症中的骨吸收,但其有益效果尚未得到确凿证实。我们研究了一组35名绝经后骨质疏松女性口服钙负荷(1克)12小时后的急性效应,其中包括19名钙吸收正常的受试者和16名钙吸收不良的受试者。在钙吸收正常的受试者中,空腹尿总羟脯氨酸/肌酐比值从0.021降至0.017(p<0.001),但在钙吸收不良的受试者中,该比值无显著变化。两组之间的这种差异具有显著性(p<0.01)。这些结果表明,口服钙负荷能迅速抑制钙吸收正常的骨质疏松受试者的骨吸收,但不能抑制钙吸收不良的受试者的骨吸收。